Morning news brief

NPR | By A Martínez,

Leila Fadel

Published November 21, 2025 at 4:43 AM EST

The CDC reversed its stance on vaccines and autism, suggesting a potential link without evidence, the U.S. presented a plan to end the war in Ukraine, NYC Mayor-elect Mamdani to meet Trump Friday.

A Martínez

A Martínez is one of the hosts of Morning Edition and Up First.

Leila Fadel

Leila Fadel is a host of Morning Edition, as well as NPR's morning news podcast Up First.

See stories by Leila Fadel

Support nonprofit, fact-based public service journalism

WEKU depends on support from those who view and listen to our content. There's no paywall here. Please support WEKU with your donation.

Contribute now

Related Content

NPR News

Major news outlets banned by Trump will have their day in court

David Folkenflik

CNN, MS NOW, and Politico are asking a federal judge to hold the president in check for what they say is a violation of their Constitutional rights simply because he doesn't like how they cover him.
NPR News

How an 'AI freeze' could make big AI companies bigger and hurt smaller firms

Bobby Allyn

Critics say a slowdown of AI development among the largest companies could consolidate the power of frontier labs, just as many others are trying to catch up.
NPR News

ICE is looking into 'mobile detention facilities'

Jasmine Garsd

Buried in the paperwork for Immigration and Customs Enforcement's expansion in Pennsylvania is a document requesting "mobile detention facilities."
NPR News

Poll: Trust in the U.S. Postal Service delivering mail-in ballots on time has fallen

Hansi Lo Wang

Registered voters are less confident that USPS will deliver election mail on time compared with 2024, an NPR/PBS News/Marist poll finds, after USPS was part of Trump's bid to limit mail voting.
NPR News

As Congress confronts AI, Senate lawmakers are shut off from its most advanced tools

Eric McDaniel

While Senate offices have access to chatbots like ChatGPT, they are not authorized to use any of the more advanced tools that are at the center of regulatory talks and public debate about AI safety.